TR199901542T2 - Alfa-2 adrenosept�r agonistleri olarak yararl� 2-imidazolinilaminoindazol bile�ikleri. - Google Patents

Alfa-2 adrenosept�r agonistleri olarak yararl� 2-imidazolinilaminoindazol bile�ikleri.

Info

Publication number
TR199901542T2
TR199901542T2 TR1999/01542T TR9901542T TR199901542T2 TR 199901542 T2 TR199901542 T2 TR 199901542T2 TR 1999/01542 T TR1999/01542 T TR 1999/01542T TR 9901542 T TR9901542 T TR 9901542T TR 199901542 T2 TR199901542 T2 TR 199901542T2
Authority
TR
Turkey
Prior art keywords
alpha
imidazolinylaminoindazole
compounds useful
adrenoceptor agonists
compounds
Prior art date
Application number
TR1999/01542T
Other languages
English (en)
Turkish (tr)
Inventor
Lee Cupps Thomas
Eva Bogdan Sophie
Todd Henry Raymond
James Sheldon Russell
Lee Seibel William
Joseph Ares Jeffrey
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of TR199901542T2 publication Critical patent/TR199901542T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
TR1999/01542T 1996-11-25 1997-11-21 Alfa-2 adrenosept�r agonistleri olarak yararl� 2-imidazolinilaminoindazol bile�ikleri. TR199901542T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3174096P 1996-11-25 1996-11-25

Publications (1)

Publication Number Publication Date
TR199901542T2 true TR199901542T2 (xx) 2000-01-21

Family

ID=21861136

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/01542T TR199901542T2 (xx) 1996-11-25 1997-11-21 Alfa-2 adrenosept�r agonistleri olarak yararl� 2-imidazolinilaminoindazol bile�ikleri.

Country Status (20)

Country Link
EP (1) EP0944620A1 (xx)
JP (1) JP2001506599A (xx)
KR (1) KR20000069104A (xx)
CN (1) CN1244864A (xx)
AR (1) AR010643A1 (xx)
AU (1) AU5433998A (xx)
BR (1) BR9713535A (xx)
CA (1) CA2272644A1 (xx)
CO (1) CO4910166A1 (xx)
CZ (1) CZ183999A3 (xx)
HU (1) HUP9904660A3 (xx)
ID (1) ID22676A (xx)
IL (1) IL130067A0 (xx)
NO (1) NO992502L (xx)
NZ (1) NZ335882A (xx)
PE (1) PE47099A1 (xx)
SK (1) SK69699A3 (xx)
TR (1) TR199901542T2 (xx)
WO (1) WO1998023609A1 (xx)
ZA (1) ZA9710576B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
US6433186B1 (en) 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
WO2009084695A1 (ja) 2007-12-28 2009-07-09 Carna Biosciences Inc. ２－アミノキナゾリン誘導体
US8555875B2 (en) 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CN112538074A (zh) * 2020-12-24 2021-03-23 艾希尔（深圳）药物研发有限公司 一种溴莫尼定脱溴杂质的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH641782A5 (en) * 1978-12-07 1984-03-15 Siegfried Ag 1H- and 2H-indazole derivatives
US4526898A (en) * 1980-09-05 1985-07-02 Siegfried Aktiengesselschaft Antihypertensive 4-(2-imidazolin-2-yl-amino)-2-methyl-indazole
US5478858A (en) * 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
DK0735877T3 (da) * 1993-12-17 2000-11-06 Procter & Gamble 6-(2-imidazolinylamino)quinoxalinforbindelser, der er egnede som alfa-2-adrenoceptoragonister.

Also Published As

Publication number Publication date
EP0944620A1 (en) 1999-09-29
KR20000069104A (ko) 2000-11-25
CN1244864A (zh) 2000-02-16
PE47099A1 (es) 1999-06-12
NZ335882A (en) 2000-12-22
HUP9904660A3 (en) 2002-02-28
NO992502D0 (no) 1999-05-25
ID22676A (id) 1999-12-09
SK69699A3 (en) 2000-06-12
NO992502L (no) 1999-07-26
IL130067A0 (en) 2000-02-29
BR9713535A (pt) 2000-03-21
CZ183999A3 (cs) 1999-11-17
CA2272644A1 (en) 1998-06-04
AU5433998A (en) 1998-06-22
CO4910166A1 (es) 2000-04-24
AR010643A1 (es) 2000-06-28
JP2001506599A (ja) 2001-05-22
ZA9710576B (en) 1998-09-16
HUP9904660A2 (hu) 2000-06-28
WO1998023609A1 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
TR199901885T2 (xx) Alfa-2 adrenosept�r agonistleri olarak yararl� 2-imidazolinilaminoindol bile�ikleri.
TR199901468T2 (xx) Alfa-2 adrenosept�r agonistleri olarak yararl� guanidinil heterosikl bile�ikleri.
TR200000671T2 (tr) FP agonistleri olarak yararlı aromatik C16-C20-ikameli tetrahidro prostaglandinler.
TR199901486T2 (xx) Alfa-2 adrenosept�r agonistleri olarak yararl� 2-imidazolinilamino-benzoksazol bile�ikleri.
TR200000670T2 (tr) FP agonistleri olarak yararlı aromatik C16-C20- ikameli tetrahidro prostaglandinler.
DK0705254T3 (da) Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer
ES2092113T3 (es) Derivados fluoroalcoxibencilamino de heterociclos que contienen nitrogeno.
BR9713186A (pt) Inibidores de metaloprotease 1,3-diheterocìclicos
TR200001435T2 (tr) Antimikrobiyal kuinolonlar, bunların bileşimleri ve kullanımları
NO20005237L (no) Heterocyklisk substituerte amider anvendt som calpain- inhibitorer
BR9712085A (pt) Inibidores de metaloprotease heterocìclicos
BR9712086A (pt) Inibidores1,4-heterocìclicos de metaloproteinases
ES2165391T3 (es) Esteres del acido metilfosfonico, procedimiento para su preparacion y su empleo.
TR200102524T2 (tr) Dihetero sübstitüe edilmiş metaloproteaz inhibitörleri.
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
BR0109348A (pt) Inibidores de metaloproteases n-substituìdos os quais contêm cadeias laterais carbocìclicas
DK0775118T3 (da) Benzimidazolderivater, der har dopaminerg aktivitet
TR199901542T2 (xx) Alfa-2 adrenosept�r agonistleri olarak yararl� 2-imidazolinilaminoindazol bile�ikleri.
TR199901467T2 (xx) Alfa-2 adrenosept�r agonistleri olarak yararl� guanidinilamino heterosikl bile�ikleri.
ES2096874T3 (es) Inhibidor de la proteasa de hiv util para el tratamiento del sida.
ES2076838T3 (es) Nuevo derivado de la isoindolinona, su preparacion y las composiciones farmaceuticas que le contienen.
BR0014759A (pt) Inibidores de metaloprotease beta dissubstituìdos
DK0966455T3 (da) Oxirancarboxylsyrer til behandling af diabetes
DE59509727D1 (de) Uracilderivate
TR200101540T2 (tr) Bakteri öldürücü etkenler olarak higromisin A türevleri